136 related articles for article (PubMed ID: 38072417)
1. Methylation of PLK-1 Potentially Drives Bendamustine Resistance in Leukemia Cells.
Itabashi T; Ueda T; Fukunaga R; Asano T; Itoh Y
J Nippon Med Sch; 2024 May; 91(2):162-171. PubMed ID: 38072417
[TBL] [Abstract][Full Text] [Related]
2. RNA interference-mediated silencing of the polo-like kinase 1 gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cells.
Yu C; Zhang X; Sun G; Guo X; Li H; You Y; Jacobs JL; Gardner K; Yuan D; Xu Z; Du Q; Dai C; Qian Z; Jiang K; Zhu Y; Li QQ; Miao Y
J Cell Mol Med; 2008 Dec; 12(6A):2334-49. PubMed ID: 18266952
[TBL] [Abstract][Full Text] [Related]
3. Overcoming PLK1 inhibitor resistance by targeting mevalonate pathway to impair AXL-TWIST axis in colorectal cancer.
Solanes-Casado S; Cebrián A; Rodríguez-Remírez M; Mahíllo I; García-García L; Río-Vilariño A; Baños N; de Cárcer G; Monfort-Vengut A; Castellano V; Fernández-Aceñero MJ; García-Foncillas J; Del Puerto-Nevado L
Biomed Pharmacother; 2021 Dec; 144():112347. PubMed ID: 34700228
[TBL] [Abstract][Full Text] [Related]
4. Bendamustine overcomes resistance to melphalan in myeloma cell lines by inducing cell death through mitotic catastrophe.
Cives M; Ciavarella S; Rizzo FM; De Matteo M; Dammacco F; Silvestris F
Cell Signal; 2013 May; 25(5):1108-17. PubMed ID: 23380051
[TBL] [Abstract][Full Text] [Related]
5. Establishment and Characteristics of a Novel Mantle Cell Lymphoma-derived Cell Line and a Bendamustine-resistant Subline.
Takimoto-Shimomura T; Nagoshi H; Maegawa S; Fujibayashi Y; Tsukamoto T; Matsumura-Kimoto Y; Mizuno Y; Chinen Y; Mizutani S; Shimura Y; Horiike S; Taniwaki M; Kobayashi T; Kuroda J
Cancer Genomics Proteomics; 2018; 15(3):213-223. PubMed ID: 29695404
[TBL] [Abstract][Full Text] [Related]
6. Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistance.
Sero V; Tavanti E; Vella S; Hattinger CM; Fanelli M; Michelacci F; Versteeg R; Valsasina B; Gudeman B; Picci P; Serra M
Invest New Drugs; 2014 Dec; 32(6):1167-80. PubMed ID: 25193492
[TBL] [Abstract][Full Text] [Related]
7. Polo-like kinase 1 is a potential therapeutic target in human melanoma.
Jalili A; Moser A; Pashenkov M; Wagner C; Pathria G; Borgdorff V; Gschaider M; Stingl G; Ramaswamy S; Wagner SN
J Invest Dermatol; 2011 Sep; 131(9):1886-95. PubMed ID: 21654832
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance to nelarabine in leukemia cell lines might be caused by reduced expression of deoxycytidine kinase through epigenetic mechanisms.
Yoshida K; Fujita A; Narazaki H; Asano T; Itoh Y
Cancer Chemother Pharmacol; 2022 Jan; 89(1):83-91. PubMed ID: 34825941
[TBL] [Abstract][Full Text] [Related]
9. The deregulated promoter methylation of the Polo-like kinases as a potential biomarker in hematological malignancies.
Ward A; Sivakumar G; Kanjeekal S; Hamm C; Labute BC; Shum D; Hudson JW
Leuk Lymphoma; 2015 Jul; 56(7):2123-33. PubMed ID: 25347426
[TBL] [Abstract][Full Text] [Related]
10. Human ABCB1 (P-glycoprotein) and ABCG2 mediate resistance to BI 2536, a potent and selective inhibitor of Polo-like kinase 1.
Wu CP; Hsiao SH; Sim HM; Luo SY; Tuo WC; Cheng HW; Li YQ; Huang YH; Ambudkar SV
Biochem Pharmacol; 2013 Oct; 86(7):904-13. PubMed ID: 23962445
[TBL] [Abstract][Full Text] [Related]
11. TrkC promotes survival and growth of leukemia cells through Akt-mTOR-dependent up-regulation of PLK-1 and Twist-1.
Kim MS; Kim GM; Choi YJ; Kim HJ; Kim YJ; Jin W
Mol Cells; 2013 Aug; 36(2):177-84. PubMed ID: 23832765
[TBL] [Abstract][Full Text] [Related]
12. siRNA targeting PLK-1 induces apoptosis of synoviocytes in rheumatoid arthritis.
Wada M; Kawahito Y; Kimura S; Kohno M; Ishino H; Kimura M; Omoto A; Yamamoto A; Hamaguchi M; Tsubouchi Y; Tokunaga D; Hojo T; Ashihara E; Maekawa T; Yoshikawa T
Biochem Biophys Res Commun; 2007 Jun; 357(2):353-9. PubMed ID: 17434144
[TBL] [Abstract][Full Text] [Related]
13. ABCB1 regulation through LRPPRC is influenced by the methylation status of the GC -100 box in its promoter.
Corrêa S; Binato R; Du Rocher B; Ferreira G; Cappelletti P; Soares-Lima S; Pinto LF; Mencalha A; Abdelhay E
Epigenetics; 2014 Aug; 9(8):1172-83. PubMed ID: 25089713
[TBL] [Abstract][Full Text] [Related]
14. Decitabine (5-Aza-2'-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells.
Ando T; Nishimura M; Oka Y
Leukemia; 2000 Nov; 14(11):1915-20. PubMed ID: 11069027
[TBL] [Abstract][Full Text] [Related]
15. Molecular and enzoinformatics perspectives of targeting Polo-like kinase 1 in cancer therapy.
Shakil S; Baig MH; Tabrez S; Rizvi SMD; Zaidi SK; Ashraf GM; Ansari SA; Khan AAP; Al-Qahtani MH; Abuzenadah AM; Chaudhary AG
Semin Cancer Biol; 2019 Jun; 56():47-55. PubMed ID: 29122685
[TBL] [Abstract][Full Text] [Related]
16. Melatonin overcomes resistance to clofarabine in two leukemic cell lines by increased expression of deoxycytidine kinase.
Yamanishi M; Narazaki H; Asano T
Exp Hematol; 2015 Mar; 43(3):207-14. PubMed ID: 25461250
[TBL] [Abstract][Full Text] [Related]
17. Impact of PLK-1 silencing on endothelial cells and cancer cells of diverse histological origin.
Gomes CP; Gomes-da-Silva LC; Ramalho JS; de Lima MC; Simões S; Moreira JN
Curr Gene Ther; 2013 Jun; 13(3):189-201. PubMed ID: 23531193
[TBL] [Abstract][Full Text] [Related]
18. Methylation of SFRP5 is related to multidrug resistance in leukemia cells.
Wang H; Wang X; Hu R; Yang W; Liao A; Zhao C; Zhang J; Liu Z
Cancer Gene Ther; 2014 Feb; 21(2):83-9. PubMed ID: 24434572
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic mechanisms involved in differential MDR1 mRNA expression between gastric and colon cancer cell lines and rationales for clinical chemotherapy.
Lee TB; Park JH; Min YD; Kim KJ; Choi CH
BMC Gastroenterol; 2008 Aug; 8():33. PubMed ID: 18673531
[TBL] [Abstract][Full Text] [Related]
20. [Expression of plk-1 gene in acute leukemia patients and its significance].
Mao HW; Liu WL; Zhou JF; Sun HY; Xu HZ; Luo XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):876-9. PubMed ID: 17096880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
